« Back to news listing

Clinical Data of the Cappella Sideguard(R) Stent System Announced at TCT 2011

SAN FRANCISCO, Nov 08, 2011 (BUSINESS WIRE) — Cappella Medical Devices Ltd (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced today at the 2011 TCT (Transcatheter Cardiovascular Therapeutics) Conference in San Francisco results from several long term studies of its Sideguard(R) technology. These studies document the need to treat coronary bifurcation disease with a dedicated sidebranch system versus the traditional provisional approach.

Read entire article: http://www.marketwatch.com/story/positive-long-term-clinical-data-of-the-cappella-sideguardr-stent-system-announced-at-tct-2011-2011-11-08

« Back to news listing